CompletedPhase 4

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Egypt100 participantsStarted 2014-12

Plain-language summary

Evaluation of the effect of altering the timing of initiation of low molecular weight heparin (LMWH) administration on the pregnancy outcomes in women with antiphospholipid syndrome (APS)

Who can participate

Age range20 Years – 38 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women with APS diagnosed according to the revised classification criteria for APS in 2006 in Sydney, Australia * Early pregnancy body weight is 50-90 Kg Exclusion Criteria: * Women with systemic lupus erythematosus (SLE) * Women with active thromboembolic disorders * Women with history of previous thromboembolic disorders

What they're measuring

Ongoing pregnancy rate

Timeframe: After 12 weeks gestational age

Trial details

NCT IDNCT02326051

SponsorMohamed Sayed Abdelhafez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-02

View on ClinicalTrials.gov More Recurrent Miscarriage trials